Patient selection for transplantation in the myelodysplastic syndromes. | Aplastic Anemia and MDS International Foundation

Patient selection for transplantation in the myelodysplastic syndromes.

Journal Title: 
Hematol Oncol Clin North Am
Author(s): 
Cutler C
Primary Author: 
Cutler C
Original Publication Date: 
Thursday, April 1, 2010

Allogeneic hematopoietic stem cell transplantation remains the only known curative procedure for the myelodysplastic syndromes (MDS). Because the median age at diagnosis for MDS is in the late seventh decade of life, despite the curative potential, transplantation is not undertaken routinely, and careful consideration must be made regarding the appropriateness of the transplant recipient. This article focuses on appropriate patient selection for transplantation for MDS.

Bone Marrow Diseases: